Education
About Us
Working with TipRanks
Follow Us
SCHF - ETF AI Analysis
Top Page
Schwab International Equity ETF (SCHF)
Rating:63Neutral
Price Target:
$24.50
Positive Factors
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective for investors.
Global Diversification
The fund provides exposure to a wide range of countries, reducing reliance on any single economy.
Strong Top Holdings Performance
Several top holdings, such as ASML Holding NV and Nestlé SA, have shown strong year-to-date performance, supporting the fund's returns.
Negative Factors
Underperforming Holdings
Some top holdings, like SAP SE and Toyota Motor, have lagged in performance, which could weigh on overall returns.
Sector Concentration in Financials
The ETF has significant exposure to the financial sector, which could increase risk if that sector faces challenges.
Limited U.S. Exposure
The fund has relatively low exposure to U.S. companies, which may limit participation in the strong U.S. market growth.
SCHF vs. SPDR S&P 500 ETF (SPY)
AUM51.78B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.73
IssuerSchwab
Inception DateNov 03, 2009
Dividend Yield2.42%
Asset ClassEquity
Index TrackedFTSE All-World Developed x US
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,097,575
30 Day Avg. Volume8,713,845
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
25.93Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1481
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCHF Summary
The Schwab International Equity ETF (SCHF) is an investment fund that lets you own shares in companies from developed countries outside the U.S., such as Japan, the UK, and Germany. It follows the FTSE Developed ex US Index and includes well-known companies like Nestlé and Toyota. This ETF is great for diversifying your portfolio and tapping into global growth opportunities. However, new investors should know that its performance depends on international markets, which can be affected by currency fluctuations and economic changes abroad.
How much will it cost me?The Schwab International Equity ETF (SCHF) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because SCHF is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?The Schwab International Equity ETF (SCHF) could benefit from global economic growth, particularly in developed markets outside the U.S., as well as advancements in sectors like technology and healthcare, which are among its top holdings. However, it may face challenges from rising interest rates, currency fluctuations, or geopolitical tensions that could negatively impact international markets and sectors like financials and energy. Regulatory changes in key regions or slower growth in developed economies could also affect its performance.
SCHF Top 10 Holdings
The Schwab International Equity ETF (SCHF) leans heavily on developed markets outside the U.S., with a notable tilt toward financials and industrials. Roche and AstraZeneca are rising stars, buoyed by strong pipelines and strategic growth in healthcare, while SAP is lagging, weighed down by bearish momentum and valuation concerns. Nestlé offers steady consumer defensive stability, though recent performance has been mixed. ASML, a key player in technology, shows promise but faces valuation headwinds. Overall, the fund’s broad sector exposure provides balance, but its reliance on a few names in healthcare and tech could shape near-term performance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.55% | $793.84M | €328.05B | 31.57% | 76 Outperform | |
| Roche Holding AG | 1.12% | $576.44M | CHF248.67B | 33.10% | 73 Outperform | |
| AstraZeneca | 1.11% | $569.88M | £216.01B | 33.03% | 76 Outperform | |
| Nestlé SA | 1.04% | $531.36M | CHF203.55B | 14.56% | 71 Outperform | |
| SAP SE | 0.99% | $509.35M | €242.18B | -7.97% | 66 Neutral | |
| Novartis AG | 0.97% | $499.92M | CHF196.03B | 12.04% | 80 Outperform | |
| HSBC Holdings | 0.97% | $498.13M | £180.00B | 42.84% | 79 Outperform | |
| Shell (UK) | 0.88% | $450.54M | £158.94B | 7.69% | 77 Outperform | |
| Royal Bank Of Canada | 0.87% | $446.48M | $210.51B | 20.42% | 75 Outperform | |
| Toyota Motor | 0.86% | $441.04M | ¥40.36T | 16.23% | 81 Outperform |
SCHF Technical Analysis
Positive
―
Price Trends
23.55
Negative
23.01
Positive
21.74
Positive
Market Momentum
-0.07
Positive
45.43
Neutral
19.44
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 23.70, equal to the 50-day MA of 23.55, and equal to the 200-day MA of 21.74, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 45.43 is Neutral, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCHF.
SCHF Peer Comparison
Comparison Results
Performance Comparison
SCHF
Schwab International Equity ETF
23.38
4.67
24.96%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
IQLT
iShares MSCI Intl Quality Factor ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents